Hosted on MSN2h
Novavax (NVAX) Outperforms Broader Market: What You Need to Know
Novavax (NVAX) closed at $8.19 in the latest trading session, marking a +0.74% move from the prior day. This move outpaced the S&P 500's daily gain of 0.67%. At the same time, the Dow added 0.38%, and ...
3,610 Shares in Novavax, Inc. (NASDAQ:NVAX) Bought by Spire Wealth Management
Spire Wealth Management bought a new position in Novavax, Inc. (NASDAQ:NVAX – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange ...
Novavax Inc. stock underperforms Friday when compared to competitors
Shares of Novavax Inc. NVAX slipped 1.69% to $8.13 Friday, on what proved to be an all-around poor trading session for the ...
Novavax Inc. stock underperforms Thursday when compared to competitors
The stock's fall snapped a two-day winning streak.
Senate panel advances Kennedy’s nomination for HHS secretary, CNBC reports
A Senate panel has voted to advance Robert F. Kennedy Jr.’s nomination to lead the Department of Health and Human Services to the full chamber, ...
RFK Jr. HHS nomination advances out of Senate Finance Committee
The Senate Finance Committee advances the nomination of Robert F. Kennedy Jr. for HHS Secretary amid a party-line vote. Read ...
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax, Inc. (NASDAQ:NVAX) About To Shift From Loss To Profit
According to the 6 industry analysts covering Novavax, the consensus is that breakeven is near. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$82m ...